Fly News Breaks for February 27, 2020
Feb 27, 2020 | 07:23 EDT
As reported previously, Cowen analyst Chris Shibutani upgraded United Therapeutics to Outperform from Market Perform with a price target of $145, up from $119. The upgrade is the underpinned by the expectations of generics competition being less severe than anticipated, and the unexpected results from the INCREASE trial which will provided a significant new market segment opportunity.
News For UTHR From the Last 2 Days
There are no results for your query UTHR